生物标志物 生物标志物
Ava Farnan1, Annabel Sorby-Adams1, Jennifer Guo1
1Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
便携式低场MRI (LF-MRI) 与机器学习相结合,准确量化了阿尔茨海默病 (AD) 患者的大脑变化. 这种可访问的神经成像方法可以在门诊环境中有效监测疾病.
科学领域:
- 神经成像是一种神经成像.
- 机器学习 机器学习
- 神经学 神经学
背景情况:
- 磁共振成像 (MRI) 对于监测阿尔茨海默病 (AD) 进展至关重要.
- 便携式低场核磁共振 (LF-MRI) 提供了治疗点的评估和改善了患者的访问.
- 开发了一种机器学习 (ML) 管道,用于使用LF-MRI量化AD患者监测的大脑形态测量.
研究的目的:
- 评估使用LF-MRI与ML用于阿尔茨海默病 (AD) 和轻度认知障碍 (MCI) 患者的大脑形态测量量的可行性.
- 为了比较从LF-MRI获得的大脑体积测量与传统高场MRI (HF-MRI).
- 评估LF-MRI在区分AD/MCI患者和患有血管并发症 (VC) 患者之间的潜力.
主要方法:
- 从门诊记忆障碍诊所招募了患有MCI,AD和VC的患者.
- 获得的LF-MRI (0.064 T) 和HF-MRI (1.5-3 T) 扫描.
- 使用基于FreeSurfer的管道 (WMH-SynthSeg) 处理了T2 FLAIR序列,以量化不同区域的大脑体积.
主要成果:
- 在所有区域中,在高频MRI和轻频MRI衍生的大脑体积之间观察到高相关性 (p <0.05).
- 皮质,白质,侧腔室,海马体和杏仁体显示出最高的相关性.
- 与VC队列相比,MCI和AD队列表现出显著的区域缩,特别是在皮质,海马和杏仁体 (p < 0.001).
结论:
- 在MCI或AD患者的临床评估中,可以采用LF-MRI.
- 应用于LF-MRI数据的ML算法产生与HF-MRI可比的脑体积.
- LF-MRI作为一种可访问的神经成像工具,用于监测认知障碍和区分患者子组.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516


